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Abstract
Third ventricle tumors are uncommon and account for 0.6 - 0.9% of all the brain tumors.
Tumors of the third ventricle are classified into primary tumors, such as colloid cysts, choroid
plexus papillomas, and ependymomas, or secondary tumors, such as craniopharyngiomas, optic
nerve gliomas, pineal tumors, and meningiomas. Third ventricular tumors are uncommon, and
their treatment involves significant morbidity and mortality. The colloid cyst has a better
surgical outcome and many approaches are available to achieve a complete cure. Choroid
plexus papilloma is also a common tumor documented with its treatment majorly based on
surgical resection. In addition to multiple treatment options for craniopharyngiomas, surgery is
the most preferred treatment option. Ependymomas also have few treatment options, with
surgical resection adopted as the first line of treatment.
Categories: Internal Medicine, Neurosurgery, Oncology
Keywords: third ventricle tumors, ependymomas, pineal tumor, meningiomas, craniopharyngiomas
Introduction And Background
Third ventricle tumors are uncommon and account for only 0.6 - 0.9% of all the brain
tumors [1]. We can classify them into primary tumors (e.g., colloid cysts, choroid plexus
papillomas, and ependymomas) or secondary tumors (e.g., craniopharyngiomas, optic nerve
gliomas, pineal tumors, and meningiomas) [2]. Third ventricle tumors also divided into the
lesions involving either the anterior, posterior, or whole of the third ventricle. The division
between the anterior and posterior portion of the third ventricle is based upon an imaginary
line connecting foramen of Monro and aqueduct. The most common intraventricular tumors in
children are choroid plexus papillomas, ependymomas, teratomas, and germinomas. Ten
percent of choroid plexus papillomas occur predominantly in children younger than five years
of age [3]. Ependymomas are the third most common primary third ventricular tumor found in
children [4]. They constitute about 8 - 15% of the neoplasms [5].
In pediatric cases, the location is intracranial while, in adults, it is spinal. Colloid cysts are
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benign intracranial tumors usually occurring in the anterior part of the third ventricle [6]. In
the young, they are assumed to be more aggressive clinically and radiologically and may require
immediate intervention [7]. They are the most common tumors detected in adults in the
anterior part of the third ventricle [3]. Their treatment involves significant morbidity and
mortality. 
The objective of this paper is to review the medical literature regarding the treatment and
outcome of third ventricle tumors, including the presentation, treatment options, and post-
treatment complications.
Review
The literature databases searched for our review were Medline and Google Scholar. The type of
articles selected was case reports, cohort studies, surgeon general’s report, retrospective
studies, and follow-up patient databases. The data collected were divided into primary and
secondary tumors of the third ventricle and further subdivided into its subtypes. Data for the
management and complications was then compiled. The data regarding patients in different age
groups were added, ranging from infants to old age. The first choice treatment option for third
ventricle lesions with dilated ventricles was endoscopic management [1]. Among microsurgical
approaches, the expanded transcallosal transforaminal approach was a more recently practiced
and safe method of accessing the anterior and middle third ventricle. With this approach, the
risk of damage to most of the vital structures, such as the fornix or the thalamus, was avoided.
The location of the junction of the anterior septal and internal cerebral vein is essential.
Preoperative magnetic resonance (MR) venography can identify the junction. Some areas
remain inaccessible, such as the anterosuperior and posterosuperior regions of the third
ventricle.
Colloid cysts
Colloid cysts are cysts containing gelatinous material and mostly located at the level of or
anterior to the foramen of Monro in the anterior aspect of the third ventricle. They represent
0.5 - 1% of intracranial tumors [8]. They are derived from either primitive neuroepithelium or
endoderm. Most patients remain asymptomatic for an extended period, whereas some can
present with vertigo, paroxysmal headaches, diplopia, memory deficits, gait disturbance,
nausea, vomiting, and weakness of the lower limbs. In extreme cases, sudden death may
occur [9]. Clinical presentation may be non-specific and heterogeneous. Colloid cysts are
commonly associated with the development of hydrocephalus. This combination has an
associated 3.1% risk of rapid death [10]. Colloid cysts have been known to cause deterioration
of consciousness due to acute hydrocephalus in patients, whereas, in others, the cysts were
discovered incidentally during epileptic seizure treatment. A prompt diagnosis of colloid cysts
should be made and treated to avoid neurological deterioration, herniation, and death. Colloid
cysts are surgically curable. There are multiple approaches to the third ventricle. Some factors
determine the most feasible approach, such as the size of the tumor, the surgeon's experience,
and the desired outcome of the operation. The expanded transcallosal transforaminal approach
is a comfortable and safe method [11]. An endoscopic excision is also a safe and minimally
invasive technique [7]. Smaller retractor tubes have been used for complete resection of colloid
cysts [12]. The endoscopic approach to colloid cysts is performed through the foramen of Monro
and considered quite a safe technique for the total resection of these cysts [13]. There are
multiple angles of visualization and illumination. An endoscopic approach may result in less
discomfort, shorter hospital stays, and fewer postoperative complications [14]. A few
postoperative complications have been observed, such as transient/permanent memory deficits,
surgical wound infection, cerebrospinal fluid (CSF) leak, meningitis, temporary potomania, and
intraventricular hemorrhage [15].
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Choroid plexus papillomas (CPP)
Choroid plexus papilloma is a rare, benign neuroepithelial intraventricular tumor of the
choroid plexus. It can cause increased cerebrospinal fluid production, leading to increased
intracranial pressure and hydrocephalus. The tumor is neuroectodermal in origin and similar in
structure to a normal choroid plexus. They most commonly affect young children under the age
of five and account for 0.4 - 0.6% of all intracranial neoplasms. Signs of the tumor resulting
from increased intracranial pressure are present in 91% of patients with vomiting,
homonymous visual field defects, and headache being the most common symptoms. Other
symptoms are ear ringing and dizziness. CPP is treated with surgery and rarely progresses to
become malignant. If it becomes malignant, patients with CPP are more likely to experience
recurrence and metastasis. Therefore, a gross total resection (GTR) with chemotherapy is
essential in preventing recurrence and prolonging survival [16]. The use of chemotherapy
remains limited for CPP because most of the tumors are benign. Surgical treatment has a better
outcome with the chances of a cure increasing to almost 100% due to recent advances in
imaging, surgical approaches, and quality of intensive care [17]. Irradiation, followed by
subtotal resection, to treat a growing residual tumor in the case of CPP provides an even higher
chance of success [18]. Safaee et al. reported the success rate of surgical intervention in CPP
[19]. Out of 24 patients, 20 underwent GTR while four had a subtotal resection (STR). Only
three patients showed recurrence at the interval of 1.6, 3.3, and 8.5 years. Due to the potential
adverse neurological sequelae associated with radiation to the developing brain,
recommendations discourage its use in children less than three years of age [18].
Where radiation is inadvisable, high-dose chemotherapy (HDCT) and autologous peripheral
blood stem cell transplantation (aPBSCT) are essential potential adjuncts in the treatment of
infants. Due to the hypervascularity of the tumor, complications may occur during surgery.
Therefore, this makes GTR challenging to achieve. Excessive bleeding leads to increased
perioperative mortality, especially in infants and young children. Koh et al. discussed various
ways that could be attempted to overcome difficulties in obtaining GTR of CPP [20]. One
method was preoperative embolization. This method, although useful, may be challenging
when it comes to passing the catheter through the tortuous feeding vessel. Therefore, one
could consider neoadjuvant chemotherapy with or without a biopsy as the alternative
treatment. Finally, chemotherapy after an initial incomplete resection decreases the size and
vascularity of tumors to facilitate GTR at the second-look surgery [20]. On magnetic resonance
imaging (MRI), they appear as homogeneous or heterogeneous tumors with a cauliflower
appearance. Papillomas are typically iso- or hypointense on T1- and T2-weighted imaging but
may demonstrate a heterogeneous hyperintensity on T2-weighted imaging; they enhance after
contrast injection unless the tumor is highly calcified [17, 21]. Computed tomography (CT) scan
revealed an isodense lobulated lesion with homogeneous contrast enhancement [21].
Craniopharyngiomas
Craniopharyngiomas are brain tumors derived from the embryonic tissue of the pituitary gland.
They are also known as Rathke’s pouch tumors, hypophyseal duct tumors, or adamantinomas.
They occur most frequently in children and also in men and women during the fifth and sixth
decades of life [22]. They are slow-growing benign tumors. Patients may present with a balance
disorder, dry skin, fever, fatigue, headache, hypersomnia and lethargy, polydipsia, polyuria,
vision loss, and endocrinological disturbances and can be diagnosed by a radiological study,
such as an MRI. Craniopharyngiomas have a very typical appearance on an MRI scan – a well-
defined mass of solid and cystic parts. As it is a benign tumor and not expected to spread
elsewhere, no further scans are required unless indicated by particular symptoms. Controversy
exists regarding the treatment of choice for craniopharyngiomas; radical surgery, subtotal
resection combined with radiotherapy, or primary irradiation are the available options [23]. The
frontolateral approach is considered safe and straightforward. It gives sufficient access to even
large craniopharyngiomas and promotes their complete removal with low to moderate
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morbidity [24]. Radical surgery is considered to be the treatment of choice as these are benign
tumors. Surgical management commonly involves various transcranial routes. The endoscopic,
endonasal, extended transsphenoidal approach is a minimal-access technique for managing
smaller tumors. Also, it has a low rate of CSF leak [25]. The ‘extended’ endonasal approach
overcomes the limits of the transsphenoidal route to the sella, enabling treatment of
suprasellar and retrosellar extensions of the tumor (Video 1) [26-27]. Gamma Knife surgery can
be useful in cases of recurrent lesions [28]. Short-term side effects from radiotherapy may
include nausea, fatigue, and mild skin reactions. With the above methods, there are significant
and comparable chances of visual improvement.
VIDEO 1: An endonasal, fully endoscopic, transplanum
transtuberculum approach for a craniopharyngioma
[27]
View video here: http://www.youtube.com/watch?v=it5mpofZl0Q&feature=youtu.be
Ependymomas
Ependymomas arise from the ependyma and are also seen with neurofibromatosis type II. They
are composed of cells with regular, round to oval nuclei. Ependymomas are a neuroepithelial
glial cell tumor. Up to 30% of intracranial ependymomas arise from the lateral or third
ventricles [29]. Ependymomas make up about 5% of adult intracranial gliomas and up to 10% of
childhood tumors of the central nervous system. Their occurrence peaks at age five years and
then again at age 35. Ependymomas are the fourth most common posterior fossa tumors in
children and constitute approximately 8 - 15% of the neoplasms [5]. Signs and symptoms
include a severe headache, visual loss (secondary to papilledema), vomiting, bilateral Babinski
sign, drowsiness, gait change (rotation of feet when walking), constipation, back pain, and
abnormal flexibility of the back. Among treatment options, surgical resection is the first line of
treatment. Studies have shown that adjuvant radiotherapy can be beneficial, but the ideal
volume of irradiation remains controversial. The use of chemotherapy remains uncertain, and
little evidence presently supports its use. Surgical treatment of intraventricular tumors has a
high operative risk and, therefore, is associated with difficulties in the gross total resection of
these tumors [30]. The prognosis for pediatric ependymomas remains relatively poor as
compared to other brain tumors. In a study with 43 patients, all less than 18 years of age,
underwent a combination of surgical excision, chemotherapy, and radiotherapy, but 16
patients died due to their ependymomas and 27 patients survived [29]. In another study, 36
patients were treated for intraventricular ependymomas and subependymoma of which 19
patients achieved complete resection while the remaining 17 underwent either subtotal or
partial resection [30]. Eight patients died after surgery due to postoperative complications. Five
patients were severely disabled postoperatively. Intraventricular ependymomas remain a
surgical challenge due to their high rate of incomplete tumor resection and permanent
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neurological complications linked to their removal. Incomplete tumor removal accompanied by
radiotherapy helps in long-term progression-free survival in a few cases [30].
Management of tumors in general
Important vascular and neural structures surround the tumors of the third ventricle. It is
essential to see which approach is most suitable for which tumor. Neuroendoscopic
management is considered to be the first and foremost line of treatment in particular with
posterior third ventricle lesions. It is a minimally invasive procedure but with a significant risk
of complications, so an experienced surgeon should perform the procedure. The same is also
true for pediatric cases. The complications were linked with the histopathological origin of the
tumor rather than the experience of the surgeon [31].
On the other hand, a biopsy is a safe procedure. A few complications were noted after surgery,
such as transient fever, nausea and vomiting, and transient double vision [1]. A
neuroendoscopic biopsy is the only treatment option available for some tumors, in particular,
non-resectable ones [32].
There are three broad categories – anterior, lateral, and posterior routes. The anterior routes
include transforaminal, interforniceal, transchoroidal, and subchoroidal. The subtemporal
route is the main lateral corridor to the third ventricle and recommended if the tumor is located
lateral to the sella turcica or extends into the middle cranial fossa [33]. The expanded
transcallosal transforaminal approach remains a safe and relatively secure method of gaining
access to the third ventricle [11]. A transtubular access to the third ventricle is also practical. It
enables blunt dissection of the corpus callosum which may minimize retraction injuries. Three-
dimensional endoscopic visualization, coupled with a transparent plastic retractor, provides
absolute and undeviating monitoring of the surgical corridor [34]. In the third ventricle's
anterior portion, the endoscopic endonasal approach permits surgical maneuverability. The
lamina terminalis and tuber cinereum are thought to be safe entry points for this approach [35].
Tumors leading to the blockage of the Sylvian aqueduct can cause obstructive hydrocephalus;
this calls for a CSF diversion procedure, endoscopic third ventriculostomy, combined with an
endoscopic biopsy. Posterior third ventricular tumors should be approached using a
combination of a rigid-flexible endoscope [36].
Conclusions
Of the four major tumors of the third ventricle discussed, colloid cysts are the most well-
documented cases. They have a better surgical outcome with many approaches to achieving
remission with safe techniques. Minor evidence regarding postoperative complications was
found. CPP is also a common tumor documented with its treatment majorly based on surgical
resection. Its success has increased to 100% with new advancements in imaging and surgical
approaches and leads to a complete cure with minor postoperative complications.
Craniopharyngiomas have multiple options for treatment with radical surgery being preferred
the most, according to the documented data. Radiotherapy has some short-term side effects,
including nausea, fatigue, and mild skin reactions. Lastly, ependymomas also have few
treatment options, with surgical resection adopted as the first line of treatment. The prognosis
for patients with ependymomas is relatively poor compared to other brain tumors with a
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